Reply by Authors (2021)

No AccessJournal of UrologyAdult Urology1 Nov 2021Reply by Authorsis a reply to letterEditorial Comment Patrick J. Hensley, Kelly K. Bree, Matthew T. Campbell, Omar Alhalabi, Andrea Kokorovic, Tanner Miest, Graciela M. Nogueras-Gonzalez, Jianjun Gao, Arlene O. Siefker-Radtke, Charles C. Guo, Neema Navai, Colin P. Dinney, and Ashish M. Kamat Patrick J. HensleyPatrick J. Hensley Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Kelly K. BreeKelly K. Bree Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Matthew T. CampbellMatthew T. Campbell Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Omar AlhalabiOmar Alhalabi Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Andrea KokorovicAndrea Kokorovic Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Tanner MiestTanner Miest Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Graciela M. Nogueras-GonzalezGraciela M. Nogueras-Gonzalez Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Jianjun GaoJianjun Gao Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Arlene O. Siefker-RadtkeArlene O. Siefker-Radtke Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Charles C. GuoCharles C. Guo Department of Pathology, University of Texas MD Anderson Cancer Center,Houston, Texas More articles by this author , Neema NavaiNeema Navai Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Colin P. DinneyColin P. Dinney Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , and Ashish M. KamatAshish M. Kamat *Correspondence: Department of Urologic Oncology, The University of Texas, MD Anderson Cancer Center, 1515 Holcolmbe Blvd., Houston, Texas 77030 telephone: 713-792-3250; FAX: 713-794-4824; E-mail Address: [email protected] http://orcid.org/0000-0002-8098-901X Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001943.02AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 206(5), p. 1267 References 1. : Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol 2017; 72: 544. Google Scholar 2. : An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun 2021; 12: 2301. Google Scholar © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology10 Aug 2021Editorial Comment Volume 206Issue 5November 2021Page: 1267-1267 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Patrick J. Hensley Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Kelly K. Bree Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Matthew T. Campbell Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Omar Alhalabi Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Andrea Kokorovic Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Tanner Miest Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Graciela M. Nogueras-Gonzalez Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Jianjun Gao Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Arlene O. Siefker-Radtke Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Charles C. Guo Department of Pathology, University of Texas MD Anderson Cancer Center,Houston, Texas More articles by this author Neema Navai Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Colin P. Dinney Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Ashish M. Kamat Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas *Correspondence: Department of Urologic Oncology, The University of Texas, MD Anderson Cancer Center, 1515 Holcolmbe Blvd., Houston, Texas 77030 telephone: 713-792-3250; FAX: 713-794-4824; E-mail Address: [email protected] More articles by this author Expand All Advertisement PDF downloadLoading ...